Literature DB >> 27123422

Preparation and Characterization of Nanosuspension of Aprepitant by H96 Process.

Sunethra Kalvakuntla1, Mangesh Deshpande2, Zenab Attari1, Koteshwara Kunnatur B1.   

Abstract

PURPOSE: Nanosuspension in drug delivery is known to improve solubility, dissolution and eventually bioavailability of the drugs. The purpose of the study was to compare particle size of nanosuspensions prepared by the first generation approach and H96 approach and to evaluate the effectiveness of H96 approach.
METHODS: The nanosuspension of aprepitant was prepared by HPH and H96 approach. The prepared nanosuspensions were characterized for their particle size and zeta potential. The optimized nanosuspension was further evaluated for DSC, FT-IR, solubility and dissolution.
RESULTS: The optimized nanosuspension (NCLH5) prepared using combination of tween 80 and poloxamer 188 as stabilizer, showed particle size of 35.82 nm and improved solubility and dissolution profile over pure drug. NCLH5 was chosen optimized formulation and further evaluated for other parameters after lyophilization. Lyophilization resulted in increase in particle size. The solubility and dissolution studies showed favorable increase in the performance. The FT-IR and DSC analysis showed change in the crystallinity after nanosizing.
CONCLUSION: The observations indicated that lyophilization prior to high pressure homogenization resulted in efficient particle size reduction yielding smaller particles than first generation preparation technique. H96 is a good and easy alternative to achieve efficient particle size reduction of drug in lesser time and increase its solubility and dissolution.

Entities:  

Keywords:  High pressure homogenization; Lyophilization; Nanosuspension; Particle size; Second generation approach

Year:  2016        PMID: 27123422      PMCID: PMC4845550          DOI: 10.15171/apb.2016.013

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  11 in total

Review 1.  Freeze-drying of nanoparticles: formulation, process and storage considerations.

Authors:  Wassim Abdelwahed; Ghania Degobert; Serge Stainmesse; Hatem Fessi
Journal:  Adv Drug Deliv Rev       Date:  2006-10-06       Impact factor: 15.470

2.  Pharmacokinetics of aprepitant after single and multiple oral doses in healthy volunteers.

Authors:  Anup K Majumdar; Laura Howard; Michael R Goldberg; Lisa Hickey; Marvin Constanzer; Paul L Rothenberg; Tami M Crumley; Deborah Panebianco; Thomas E Bradstreet; Arthur J Bergman; Scott A Waldman; Howard E Greenberg; Kathleen Butler; A Knops; Inge De Lepeleire; Nicole Michiels; Kevin J Petty
Journal:  J Clin Pharmacol       Date:  2006-03       Impact factor: 3.126

Review 3.  Physical and chemical stability of drug nanoparticles.

Authors:  Libo Wu; Jian Zhang; Wiwik Watanabe
Journal:  Adv Drug Deliv Rev       Date:  2011-02-21       Impact factor: 15.470

4.  A combined bottom-up/top-down approach to prepare a sterile injectable nanosuspension.

Authors:  Xi Hu; Xi Chen; Ling Zhang; Xia Lin; Yu Zhang; Xing Tang; Yanjiao Wang
Journal:  Int J Pharm       Date:  2014-06-11       Impact factor: 5.875

5.  Process optimization of a novel production method for nanosuspensions using design of experiments (DoE).

Authors:  Jaime Salazar; Oliver Heinzerling; Rainer H Müller; Jan P Möschwitzer
Journal:  Int J Pharm       Date:  2011-09-10       Impact factor: 5.875

6.  Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches.

Authors:  Jaime Salazar; Antoine Ghanem; Rainer H Müller; Jan P Möschwitzer
Journal:  Eur J Pharm Biopharm       Date:  2012-01-02       Impact factor: 5.571

7.  Preparation and characterization of monensin loaded PLGA nanoparticles: in vitro anti-malarial activity against Plasmodium falciparum.

Authors:  Ranu Surolia; Manendra Pachauri; Prahlad Chandra Ghosh
Journal:  J Biomed Nanotechnol       Date:  2012-02       Impact factor: 4.099

8.  Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.

Authors:  Sant P Chawla; Steven M Grunberg; Richard J Gralla; Paul J Hesketh; Cindy Rittenberg; Mary E Elmer; Carrie Schmidt; Arlene Taylor; Alexandra D Carides; Judith K Evans; Kevin J Horgan
Journal:  Cancer       Date:  2003-05-01       Impact factor: 6.860

9.  The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.

Authors:  Paul J Hesketh; Steven M Grunberg; Richard J Gralla; David G Warr; Fausto Roila; Ronald de Wit; Sant P Chawla; Alexandra D Carides; Juliana Ianus; Mary E Elmer; Judith K Evans; Klaus Beck; Scott Reines; Kevin J Horgan
Journal:  J Clin Oncol       Date:  2003-10-14       Impact factor: 44.544

10.  Characterization and Pharmacokinetic Study of Aprepitant Solid Dispersions with Soluplus®.

Authors:  Jinwen Liu; Meijuan Zou; Hongyu Piao; Yi Liu; Bo Tang; Ying Gao; Ning Ma; Gang Cheng
Journal:  Molecules       Date:  2015-06-19       Impact factor: 4.411

View more
  7 in total

1.  The Nanosuspension Formulations of Daidzein: Preparation and In Vitro Characterization

Authors:  Afife Büşra Uğur Kaplan; Naile Öztürk; Meltem Çetin; İmran Vural; Tuba Öznülüer Özer
Journal:  Turk J Pharm Sci       Date:  2022-02-28

2.  Preparation of Vitexin Nanoparticles by Combining the Antisolvent Precipitation and High Pressure Homogenization Approaches Followed by Lyophilization for Dissolution Rate Enhancement.

Authors:  Chengbo Gu; Ziwei Liu; Xiaohan Yuan; Wang Li; Yuangang Zu; Yujie Fu
Journal:  Molecules       Date:  2017-11-22       Impact factor: 4.411

3.  ZnO Nanoparticles of Rubia cordifolia Extract Formulation Developed and Optimized with QbD Application, Considering Ex Vivo Skin Permeation, Antimicrobial and Antioxidant Properties.

Authors:  Jasmeet Kaur; Md Khalid Anwer; Ali Sartaj; Bibhu Prasad Panda; Abuzer Ali; Ameeduzzafar Zafar; Vinay Kumar; Sadaf Jamal Gilani; Chandra Kala; Mohamad Taleuzzaman
Journal:  Molecules       Date:  2022-02-21       Impact factor: 4.411

4.  Smartcrystals for Efficient Dissolution of Poorly Water-Soluble Meloxicam.

Authors:  Rita Ambrus; Areen Alshweiat; Piroska Szabó-Révész; Csilla Bartos; Ildikó Csóka
Journal:  Pharmaceutics       Date:  2022-01-21       Impact factor: 6.321

5.  Preparation of PLGA Nanoparticles by Milling Spongelike PLGA Microspheres.

Authors:  Jimin Lee; Hongkee Sah
Journal:  Pharmaceutics       Date:  2022-07-24       Impact factor: 6.525

6.  Fabrication of a Double Core-Shell Particle-Based Magnetic Nanocomposite for Effective Adsorption-Controlled Release of Drugs.

Authors:  Manzoor Hussain; Touseef Rehan; Khang Wen Goh; Sayyed Ibrahim Shah; Abbas Khan; Long Chiau Ming; Nasrullah Shah
Journal:  Polymers (Basel)       Date:  2022-06-30       Impact factor: 4.967

Review 7.  Progress in the development of stabilization strategies for nanocrystal preparations.

Authors:  Jingru Li; Zengming Wang; Hui Zhang; Jing Gao; Aiping Zheng
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.